°æ±âµµ°æÁ¦°úÇÐÁøÈï¿ø "¹ÙÀÌ¿À°æÁ¦ÀÇ ¹Ì·¡¸¦ ¿³º¸´Ù"...., ±¤±³ ¹ÙÀÌ¿ÀÇコ Æ÷·³ °³¸· ¿ì¹Î±â±âÀÚ woomin80@sudokwon.com |
2023³â 11¿ù 27ÀÏ(¿ù) 17:18 |
|
'¹ÙÀÌ¿À ±â¼úâ¾÷ÀÌ À̲ô´Â ¹ÙÀÌ¿À°æÁ¦'¶ó´Â ÁÖÁ¦·Î ÁøÇàµÇ´Â À̹ø Æ÷·³Àº ¹ÙÀÌ¿À R&D Çõ½ÅÀ» À§ÇÑ ÁÖ¿ä Á¤Ã¥°ú Ãֽűâ¼ú µ¿Çâ ¹× »ç¾÷È ¼º°ø»ç·Ê µîÀ» °øÀ¯Çϱâ À§ÇØ ¸¶·ÃµÆ´Ù.
°æ±âµµ»êÇÐÇùÀÇü, Çѱ¹¹ÙÀÌ¿À°æÁ¦ÇÐȸ, ¸Þµð¹ÙÀÌ¿À ÇٽɼÒÀç »ê¾÷Çõ½Å±â¹Ý±¸Ãà »ç¾÷´Ü, Èú¸µÄÉ¾î ½ÇÁõÁö¿ø »ç¾÷´Ü, ¼º±Õ°ü´ëÇб³ Â÷¼¼´ë ¹ÙÀÌ¿ÀÇコ»ê¾÷ Çõ½ÅÀÎÀç¾ç¼º»ç¾÷´Ü, ¾ÆÁÖ´ëÇб³ 4´Ü°è BK21 Ä͹ÙÀÌ¿À¸Þµð½Å ±³À°¿¬±¸´ÜÀÌ Âü¿©ÇÑ À̹ø Æ÷·³Àº 2°³ÀÇ ¼¼¼ÇÀ» ÅëÇØ ¹ÙÀÌ¿À°æÁ¦ ½ºÅ¸Æ®¾÷ »ýÅ°è, ¹ÙÀÌ¿À À¶ÇÕ±â¼úÀÇ »ó¾÷È µµÀü°ú ¼º°ø »ç·Ê µîÀÌ ¼Ò°³µÉ ¿¹Á¤ÀÌ´Ù.
1ºÎ¿¡¼´Â '°æ±âµµ ¹ÙÀÌ¿ÀŬ·¯½ºÅÍ ºñÀü°ú ¹ÙÀÌ¿À½ºÅ¸Æ®¾÷ Àü¸Á'À̶ó´Â ÁÖÁ¦·Î ¡ãÇѱ¹°øÇдëÇб³ ÃÖ¼öÁø ±³¼öÀÇ 'Çѱ¹ ¹ÙÀÌ¿À º¥Ã³ÀÇ ÇöÀç¿Í ¹Ì·¡' ¡ãÇѱ¹°úÇбâ¼ú±âȹÆò°¡¿ø ±èÁÖ¿ø »ý¸í±âÃÊ»ç¾÷¼¾ÅÍÀåÀÇ '°æ±âµµ ¹ÙÀÌ¿ÀŬ·¯½ºÅÍÀÇ À§»ó°ú ÇâÈÄ ¹ßÀü ¹æÇâ'¿¡ ´ëÇÑ ¹ßÇ¥°¡ À̾îÁø´Ù. ¹ßÇ¥ ÈÄ¿¡´Â Çѱ¹¹ÙÀÌ¿À°æÁ¦ÇÐȸ ÃÖ¼ºÈ£ ȸÀåÀÇ ÁÖÀç·Î ÆгÎÅä·ÐÀÌ ¿¹Á¤µÇ¾î ÀÖ´Ù.
2ºÎ¿¡¼´Â ¡ã'¹ÙÀÌ¿À Çõ½Å±â¼úÀÇ »êÇÐÇù·Â µ¿¹Ý¼ºÀå'À̶ó´Â ¼¼¼Ç ÁÖÁ¦·Î ÇѾç´ëÇб³ Á¶¿ë¿ì ±³¼öÀÇ 'Taking Exosome Therapeutics from Academia to Industry' ¡ã(ÁÖ)¿¡½º¿£ÄÉÀÌÅ׶óǻƽ½º ÃÖ»óµ· ´ëÇ¥ÀÇ 'Toll-like Receptors : The Jekyll and Hyde of Immune Responses' ¡ã ¢ßÄɾîÆ÷À¯ ¼º±âÈÆ CTOÀÇ 'Ç÷¾×±â¹ÝÀÇ POCT Áø´Ü±â±â °³¹ß ¹× ½ÇÁõ »ç¾÷À» ÅëÇÑ ÇØ¿Ü ÁøÃâ' ¡ã°æºÏ´ëÇб³ Á¶µ¿Çü ±³¼öÀÇ '¼¼Æ÷¼Ò±â°ü ÀÚ°¡Æ÷½Ä Á¦¾î ¼ÒÀç °³¹ß ¹× »ç¾÷È Àü·«'¿¡ ´ëÇÑ ¹ßÇ¥°¡ ¿¹Á¤µÇ¾î ÀÖ´Ù.
°¼ºÃµ °æ°ú¿ø ¿øÀåÀº "À̹ø Æ÷·³ÀÌ, »ê¡¤ÇС¤¿¬¡¤º´¡¤°ü Àü¹®°¡µé °£ÀÇ Çù·ÂÀ» µ½°í, ¹ÙÀÌ¿À»ê¾÷ÀÇ ¹Ì·¡¸¦ ÇÔ²² ¸ð»öÇÏ´Â ¼ÒÅëÀÇ ÀåÀÌ µÇ±â¸¦ ¹Ù¶õ´Ù"¸ç "¹ÙÀÌ¿À ½ºÅ¸Æ®¾÷ È°¼ºÈ ¹× ¹ÙÀÌ¿À°æÁ¦ È®ÀåÀ» À§ÇØ ´õ ¸¹Àº ±âȸ¸¦ ¸¸µå´Âµ¥ Èû¾²°Ú´Ù"°í ¹àÇû´Ù.
Æ÷·³Àº º°µµ Âü°¡ºñ ¾øÀÌ ´©±¸³ª Âü¿© °¡´ÉÇϸç, Æ÷·³¿¡ ´ëÇÑ º¸´Ù ÀÚ¼¼ÇÑ ³»¿ëÀº °æ°ú¿ø ¹ÙÀÌ¿À½ºÅ¸Æ®¾÷ÆÀ(031-888-6162/6107)¿¡°Ô ¹®ÀÇÇϰųª °æ°ú¿ø ȨÆäÀÌÁö(www.gbsa.or.kr), ÀÌÁöºñÁî ȨÆäÀÌÁö(www.egbiz.or.kr)¿¡¼ È®ÀÎÇÒ ¼ö ÀÖ´Ù.
|
<ÀúÀÛ±ÇÀÚ ¨Ï ¼öµµ±ÇÀϺ¸ (www.sudokwon.com) ¹«´ÜÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>